Michael Zornitzer
Psychiatry · Livingston, NJNPI 1033275813
Payments from drug & device makers
Across 269 payments — averaging $14.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$437
- Neos Therapeutics, LP$411
- Lundbeck LLC$345
- Supernus Pharmaceuticals, Inc.$187
- Axsome Therapeutics, Inc.$149
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $1,152 |
| Otsuka America Pharmaceutical, Inc. | 31 | $437 |
| Neos Therapeutics, LP | 29 | $411 |
| Lundbeck LLC | 23 | $345 |
| Supernus Pharmaceuticals, Inc. | 10 | $187 |
| Axsome Therapeutics, Inc. | 10 | $149 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $149 |
| Sunovion Pharmaceuticals Inc. | 8 | $116 |
| Idorsia Pharmaceuticals US Inc | 8 | $114 |
| Bausch Health US, LLC | 8 | $111 |
| Johnson & Johnson | 8 | $110 |
| Jazz Pharmaceuticals Inc. | 7 | $95 |
| Shire North American Group Inc | 5 | $68 |
| Neurocrine Biosciences, Inc. | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $51 |
| Vertical Pharmaceuticals, LLC | 3 | $40 |
| Avanir Pharmaceuticals, Inc. | 3 | $39 |
| Orexo US, Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Novo Nordisk | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,767 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 22 | $30,416 |
| RexultiBrexpiprazole | 15 | $27,593 |
| Armodafinil | 13 | $4,547 |
| Bupropion XlBupropion Hcl | 118 | $3,673 |
| Quetiapine Fumarate | 37 | $2,733 |
| Escitalopram Oxalate | 203 | $2,224 |
| Clonazepam | 204 | $2,124 |
| Duloxetine Hcl | 68 | $1,822 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 35 | $1,751 |
| Olanzapine | 37 | $1,736 |
| Trazodone Hcl | 133 | $1,357 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $1,348 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 89 | $1,286 |
| Alprazolam | 198 | $1,187 |
| Aripiprazole | 24 | $1,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,152 | $30,41622 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $437 | $27,59315 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $697122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Livingston
- Marc CantillonLivingston$524K
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.